These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 734979)
1. [Collagen metabolism in systemic scleroderma]. Lebedev DA Vopr Med Khim; 1978; 24(6):789-95. PubMed ID: 734979 [TBL] [Abstract][Full Text] [Related]
2. [Metabolism of collagen in progressive scleroderma and dermatomyositis]. Kreysel HW; Blonck-Kranold D; Osborn H; Kimmig J Hautarzt; 1976 May; 27(5):226-33. PubMed ID: 783083 [TBL] [Abstract][Full Text] [Related]
3. [The effect of cyclic nucleotides on the specific binding of estradiol by skin fibroblasts in the normal state and in systemic scleroderma]. Kashnikova LN; Iaroshchuk GV; Panasiuk AF; Grozdova MD Vopr Med Khim; 1991; 37(1):77-9. PubMed ID: 1650059 [TBL] [Abstract][Full Text] [Related]
4. [Possible role of natural cytotoxicity in impairment of collagen catabolism in focal scleroderma]. Prozorovskaia NN; Suchkova TN; Suchkov SV; Del'vig AA Vopr Med Khim; 1988; 34(1):95-100. PubMed ID: 3369133 [TBL] [Abstract][Full Text] [Related]
5. [Effect of isoproterenol on collagen synthesis in cultured skin fibroblasts in patients with systemic scleroderma]. Khokhova IuV; Panasiuk AF; Grozdova MD Vopr Med Khim; 1984; 30(6):92-4. PubMed ID: 6098995 [TBL] [Abstract][Full Text] [Related]
6. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). Buckingham RB; Prince RK; Rodnan GP; Taylor F J Lab Clin Med; 1978 Jul; 92(1):5-21. PubMed ID: 351108 [No Abstract] [Full Text] [Related]
7. [Formation and destruction of the skin collagen structures in systemic scleroderma]. Iakovleva GI; Mul'diiarov PIa; Gritsman NN Arkh Patol; 1978; 40(11):28-35. PubMed ID: 736818 [TBL] [Abstract][Full Text] [Related]
8. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine. Uitto J; Helin P; Rasmussen O; Lorenzen I Ann Clin Res; 1970 Sep; 2(3):228-34. PubMed ID: 5473163 [No Abstract] [Full Text] [Related]
9. [Characteristics of collagen protein biosynthesis in fibroblast cultures from the skin of patients with systemic scleroderma]. Vladimirtsev VA; Guseva NG; Khokhlova IuV; Oskilko TG Vopr Revm; 1981; (2):44-50. PubMed ID: 6275609 [No Abstract] [Full Text] [Related]
10. Mature type of skin collagen crosslink, histidinohydroxylysinonorleucine, is significantly increased in the skin of systemic sclerosis patients. Ishikawa O; Kondo A; Miyachi Y Arthritis Rheum; 1998 Feb; 41(2):376-7. PubMed ID: 9485099 [No Abstract] [Full Text] [Related]
11. [Metabolism of the connective tissue in generalized scleroderma]. Kucharz EJ; Sierakowski SJ Postepy Hig Med Dosw; 1989; 43(1):93-102. PubMed ID: 2697876 [TBL] [Abstract][Full Text] [Related]
12. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts. Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700 [TBL] [Abstract][Full Text] [Related]
13. [Electron microscopy study of pathological collagen fibril formation in systemic scleroderma]. Ptashekas RS; Vaĭtkene DI Arkh Patol; 1984; 46(7):49-54. PubMed ID: 6477175 [TBL] [Abstract][Full Text] [Related]
15. [The connection between the decomposition of mature collagen and the level of natural cytotoxicity in patients with focal scleroderma]. Prozorovskaia NN; Suchkova TN; Kozlov EA; Suchkov SV; Prokhorova TA; Del'vig AA Vopr Med Khim; 1991; 37(2):54-6. PubMed ID: 1897196 [TBL] [Abstract][Full Text] [Related]
16. [Apatite and collagen as constituents of the calcium deposits in progressive scleroderma]. Brenke A; Haupt R; Loreck D Dermatol Monatsschr; 1986; 172(4):235-7. PubMed ID: 3721031 [No Abstract] [Full Text] [Related]
17. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. Vuorio T; Kähäri VM; Black C; Vuorio E J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219 [TBL] [Abstract][Full Text] [Related]
18. [Problems and observations on progressive systemic scleroderma]. Gräfenstein K Z Gesamte Inn Med; 1985 Jul; 40(14):413-7. PubMed ID: 4049977 [TBL] [Abstract][Full Text] [Related]
19. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427 [TBL] [Abstract][Full Text] [Related]
20. [Increased retraction of collagen lattices by fibroblasts from patients with scleroderma]. Gillery P; Maquart FX; Kalis B; Borel JP C R Acad Sci III; 1986; 303(3):59-64. PubMed ID: 3093006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]